LIR Life Sciences Corp. (CSE:SKNY)

LIR Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Feb 26, 2026	Apr 30, 2025	Apr 30, 2024
Debt / Equity Ratio	-	-	-7.06
Net Debt / Equity Ratio	-1.55	1.47	0.00
Quick Ratio	2.12	0.60	0.88
Current Ratio	2.14	0.60	0.88
Return on Assets (ROA)	-	-121.98%	-
Return on Capital Employed (ROCE)	-82.20%	387.10%	300.00%
Buyback Yield / Dilution	-	-42046.80%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.